Abstract

ObjectiveTo evaluate disease characteristics and survival according to BRCA status, administration of poly-(ADP-ribose) polymerase inhibitors (PARPi), and surgery in patients with ovarian cancer and brain metastases.MethodsThis is a monocentric retrospective...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
B.J Monk ... U.A Matulonis
Annals of Oncology | VOL. 28
B.J Monk, et. al.B.J Monk ... U.A Matulonis
01 Mar 2017
Research Highlights
Biomarkers in Medicine | VOL. 4
01 Dec 2010
Real-world clinical outcomes with poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitors as second-line maintenance therapy in patients with recurrent ovarian cancer in the United States (353)
Izabela Malinowska ... Linda Kalilani
Gynecologic Oncology | VOL. 166
Izabela Malinowska, et. al.Izabela Malinowska ... Linda Kalilani
01 Aug 2022
31P Survival outcomes in BRCA pathogenetic mutated, variant of unknown significance, and wild type ovarian cancer patients treated with PARP inhibitors
V Ghizzoni ... M.V Carbone
Annals of Oncology | VOL. 33
V Ghizzoni, et. al.V Ghizzoni ... M.V Carbone
01 Jun 2022
View more papers

More From: International Journal of Gynecologic Cancer

Paper Title
Journal
Date
Author
Can international standards in ovarian cancer treatment be attained by low- and middle-income countries?
Daniel Sanabria ... Adriana Ramos
International Journal of Gynecologic Cancer | VOL. -
Daniel Sanabria, et. al.Daniel Sanabria ... Adriana Ramos
24 May 2024
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
Eric Rios-Doria ... Mario M Leitao
International Journal of Gynecologic Cancer | VOL. -
Eric Rios-Doria, et. al.Eric Rios-Doria ... Mario M Leitao
23 May 2024
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)
Agnieszka Michael ... Jonathan Ledermann
International Journal of Gynecologic Cancer | VOL. -
Agnieszka Michael, et. al.Agnieszka Michael ... Jonathan Ledermann
17 May 2024
Predictive value of SUVmax from initial 18F-FDG PET/CT scans for treatment outcomes in endometrial cancer patients undergoing fertility sparing management
Ok-Ju Kang ... Jeong-Yeol Park
International Journal of Gynecologic Cancer | VOL. -
Ok-Ju Kang, et. al.Ok-Ju Kang ... Jeong-Yeol Park
16 May 2024
View more papers